Publication Date
| In 2026 | 0 |
| Since 2025 | 0 |
| Since 2022 (last 5 years) | 0 |
| Since 2017 (last 10 years) | 0 |
| Since 2007 (last 20 years) | 1 |
Descriptor
| Anatomy | 1 |
| Brain | 1 |
| Child Development | 1 |
| Classification | 1 |
| Comparative Analysis | 1 |
| Diagnostic Tests | 1 |
| Epilepsy | 1 |
| Infants | 1 |
| Metabolism | 1 |
| Neurological Impairments | 1 |
| Physical Disabilities | 1 |
| More ▼ | |
Source
| Developmental Medicine &… | 1 |
Author
| Artuch, R. M. D. | 1 |
| Campistol, J. M. D. | 1 |
| Fernandez-Alvarez, E. | 1 |
| Garcia-Cazorla, A. | 1 |
| Gonzalez, V. | 1 |
| Ormazabal, A. | 1 |
| Perez-Duenas, B. | 1 |
| Pineda, M. | 1 |
| Serrano, M. | 1 |
Publication Type
| Journal Articles | 1 |
| Reports - Research | 1 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewed
Direct linkGarcia-Cazorla, A.; Serrano, M.; Perez-Duenas, B.; Gonzalez, V.; Ormazabal, A.; Pineda, M.; Fernandez-Alvarez, E.; Campistol, J. M. D.; Artuch, R. M. D. – Developmental Medicine & Child Neurology, 2007
Neurotransmitters are essential in young children for differentiation and neuronal growth of the developing nervous system. We aimed to identify possible factors related to secondary neurotransmitter abnormalities in pediatric patients with neurological disorders. We analyzed cerebrospinal fluid (CSF) and biogenic amine metabolites in 56 infants…
Descriptors: Anatomy, Symptoms (Individual Disorders), Infants, Neurological Impairments
